ClinConnect ClinConnect Logo
Search / Trial NCT06115200

Norwegian Adult Mental Health Registry

Launched by HELSE STAVANGER HF · Nov 1, 2023

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Database Epidemiology Mental Health Register

ClinConnect Summary

The Norwegian Adult Mental Health Registry (NAMHR) is a study aimed at improving mental health care for adults in Norway. It collects information about patients dealing with conditions like depression, schizophrenia, bipolar disorder, and anxiety, among others. By gathering and organizing this data, the registry helps health professionals evaluate and enhance the treatment provided to these patients. If you are an adult living in Norway, aged 18 or older, and are receiving treatment for a mental health issue, you might be eligible to participate.

If you choose to take part, your information will be automatically included in the registry, but you can opt out at any time without affecting your treatment. This study is not currently recruiting participants yet, but it's designed to ensure that the care you receive is as effective as possible. Your involvement could contribute to better mental health services for everyone in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Residents in Norway aged 18 years or older assessed and granted right to treatment in specialized mental in- and out-patient settings
  • Exclusion Criteria:
  • Persons who have reserved themselves against participation
  • Persons already included in more specialized register for mental disorder and/or treatment

About Helse Stavanger Hf

Helse Stavanger HF is a leading healthcare organization based in Norway, dedicated to providing high-quality medical services and advancing clinical research. As a prominent sponsor of clinical trials, Helse Stavanger HF focuses on innovative therapeutic interventions across various medical fields, aiming to enhance patient care and outcomes. With a commitment to ethical research practices and collaboration with academic institutions, the organization plays a vital role in the development of new treatments and the improvement of healthcare standards in the region and beyond.

Locations

Patients applied

0 patients applied

Trial Officials

Inge Joa, PhD

Principal Investigator

Stavanger University hospital, Stavanger, Norway

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported